Treating tobacco dependency in cancer care: essential, cost-effective, and feasible, yet overlooked Epidemiology

被引:0
|
作者
Sheikh, Mahdi [1 ]
Evison, Matthew [2 ,3 ]
机构
[1] Int Agcy Res Canc IARC, WHO, Genom Epidemiol Branch, Lyon, France
[2] Manchester Univ NHS Fdn Trust, Wythenshawe Hosp, Lung Canc & Thorac Surg Directorate, Southmoor Rd, Manchester M23 9LT, England
[3] Univ Manchester, Fac Biol Med & Hlth, Manchester Acad Hlth Sci Ctr MAHSC, Manchester, England
关键词
CESSATION; SMOKING;
D O I
10.1038/s41416-025-02957-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Treating tobacco dependency in patients diagnosed with cancer delivers substantial benefits; improved overall survival, reduced risk of disease recurrence, less treatment-related adverse events and improved quality of life. This study by Mullen et al provides important data on cost-savings and return on investment from embedding tobacco dependency treatment within cancer care and is a call to arms for equitable access to these treatments for all patients diagnosed with cancer.
引用
收藏
页码:585 / 586
页数:2
相关论文
共 50 条
  • [41] Cost-effective, portable, patient-dedicated three-dimensional automated breast ultrasound for point-of-care breast cancer screening
    Claire Keun Sun Park
    Tiana Trumpour
    Amal Aziz
    Jeffrey Scott Bax
    David Tessier
    Lori Gardi
    Aaron Fenster
    Scientific Reports, 13 (1)
  • [42] Cost-effective, portable, patient-dedicated three-dimensional automated breast ultrasound for point-of-care breast cancer screening
    Park, Claire Keun Sun
    Trumpour, Tiana
    Aziz, Amal
    Bax, Jeffrey Scott
    Tessier, David
    Gardi, Lori
    Fenster, Aaron
    SCIENTIFIC REPORTS, 2023, 13 (01):
  • [43] IS ADDING RIBOCICLIB TO FULVESTRANT COST-EFFECTIVE IN TREATING POST-MENOPAUSAL WOMEN WITH HR+/ HER2-ADVANCED BREAST CANCER - A US PAYER PERSPECTIVE COST-UTILITY ANALYSIS
    Berrios, K.
    Burum, A.
    Jeong, E.
    Zhong, L.
    VALUE IN HEALTH, 2022, 25 (07) : S425 - S425
  • [44] Teleradiotherapy Network: Applications and Feasibility for Providing Cost-Effective Comprehensive Radiotherapy Care in Low- and Middle-Income Group Countries for Cancer Patients
    Datta, Niloy Ranjan
    Heuser, Michael
    Samiei, Massoud
    Shah, Ragesh
    Lutters, Gerd
    Bodis, Stephan
    TELEMEDICINE AND E-HEALTH, 2015, 21 (07) : 523 - 532
  • [45] COST-EFFECTIVE STUDY OF ALECTINIB IN TREATING CRIZOTINIB-FAILED ANAPLASTIC LYMPHOMA KINASE POSITIVE (ALK plus ) NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS IN TAIWAN
    Liao, C.
    Wang, C.
    Chan, K. A.
    Hsiao, F.
    VALUE IN HEALTH, 2018, 21 : S34 - S34
  • [47] Pharmacoeconomic (PE) analysis of the treatment of non-small cell lung cancer (NSCLC) in the Netherlands demonstrates that erlotinib dominates docetaxel and is cost-effective over best supportive care (BSC) without need for patient stratification
    Pompen, M.
    Novak, A.
    Postmus, P.
    Gok, M.
    Gyldmark, M.
    VALUE IN HEALTH, 2006, 9 (06) : A203 - A203
  • [48] ADDING ZOLEDRONIC ACID TO ENDOCRINE THERAPY IN PREMENOPAUSAL WOMEN WITH HORMONE-RESPONSIVE EARLY BREAST CANCER CAN BE COST-EFFECTIVE FROM ITALIAN, SPANISH, AND PORTUGUESE HEALTH-CARE PERSPECTIVES, BASED ON THE ABCSG-12 TRIAL
    Taneja, C.
    Delea, T. E.
    Kaura, S.
    Sternini, P.
    Gerzeli, S.
    Gnant, M.
    VALUE IN HEALTH, 2010, 13 (07) : A265 - A265
  • [49] CLINICAL TRIAL PROTOCOL - IMPLEMENTING CLINICAL PRACTICE GUIDELINES FOR CANCER PAIN IN ADULTS TO ENSURE EQUITABLE, COST-EFFECTIVE, EVIDENCE-BASED, PERSON-CENTRED CARE: A PHASE III PRAGMATIC STEPPED WEDGE CLUSTER RANDOMISED CONTROLLED TRIAL OF GUIDELINES AND SCREENING WITH IMPLEMENTATION STRATEGIES VERSUS GUIDELINES AND SCREENING ALONE TO IMPROVE PAIN IN ADULTS WITH CANCER ATTENDING OUTPATIENTS ONCOLOGY AND PALLIATIVE CARE CENTRES
    Lovell, Melanie
    Luckett, Tim
    Phillips, Jane
    Agar, Meera
    Ryan, Louise
    Lam, Lawrence
    McCaffrey, Nikki
    Boyle, Fran
    Stubbs, John
    Shaw, Tim
    Currow, David
    Hosie, Annmarie
    Davidson, Patricia
    Asia-Pacific Journal of Clinical Oncology, 2015, 11 : 162 - 162
  • [50] Pre-chemotherapy clinically-guided skin tattooing þ post-chemotherapy USG-guided skin marking: A time-tested, cost-effective technique for breast lesion localization, before Breast Conservation Surgery (BCS), in a high volume tertiary care cancer hospital
    Sena, Anitha
    Jacob, Akhil Thomas
    Bhargavan, Rexeena
    Augustine, Paul
    Cherian, Kurian
    EJSO, 2024, 50 (09):